In today’s recent session, 5.83 million shares of the Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) have been traded, and its beta is 4.30. Most recently the company’s share price was $1.86, and it changed around -$0.27 or -12.88% from the last close, which brings the market valuation of the company to $2.36M. RDHL at last check was trading at a discount to its 52-week high of $20.27, offering almost -989.78% off that amount. The share price’s 52-week low was $1.80, which indicates that the recent value has risen by an impressive 3.23% since then. We note from Redhill Biopharma Ltd. ADR’s average daily trading volume that its 10-day average is 44360.0 shares, with the 3-month average coming to 94.19K.
Redhill Biopharma Ltd. ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended RDHL as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Redhill Biopharma Ltd. ADR is expected to report earnings per share of 0 for the current quarter.
Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) trade information
Instantly RDHL has been showing red trend so far today with a performance of -12.88% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.30 on recent trading dayincreased the stock’s daily price by 43.64%. The company’s shares are currently down -70.05% year-to-date, but still down -31.11% over the last five days. On the other hand, Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) is -34.96% down in the 30-day period. We can see from the shorts that 29973.0 shares have been sold at a short interest cover period of 0.26 day(s).
RDHL Dividends
Redhill Biopharma Ltd. ADR’s next quarterly earnings report is expected to be released on 2022-Nov-06.
Redhill Biopharma Ltd. ADR (NASDAQ:RDHL)’s Major holders
Upon looking at major shareholders, 4.83% of them are in the hands of institutional investors. The stock currently has a share float of 4.83%.
The former held 41.0 shares worth $77.0, making up 0.00% of all outstanding shares.
